Filter
3296
Filtered Results: 3296
Text search:
TB
drugs
Featured
Recommendations
279
New Publications
956
Language
Document type
No document type
2229
Studies & Reports
368
Guidelines
330
Manuals
108
Strategic & Response Plan
92
Fact sheets
51
Situation Updates
47
Training Material
43
Infographics
15
Resource Platforms
6
Brochures
3
Online Courses
3
Videos
1
Countries / Regions
India
196
Kenya
121
South Africa
112
Western and Central Europe
89
Global
81
Ethiopia
80
Uganda
78
Tanzania
76
Zambia
72
Nepal
67
Malawi
62
Nigeria
61
Eastern Europe
58
Sierra Leone
55
Liberia
51
Rwanda
48
Namibia
48
Ghana
46
Africa
45
Ukraine
42
Bangladesh
41
Myanmar / Burma
41
Lesotho
38
Latin America and the Carribbean
34
Philippines
33
Cambodia
33
Asia
31
Indonesia
31
Zimbabwe
29
Botswana
24
South–East Asia Region
23
Senegal
20
Russia
20
Colombia
17
Mozambique
17
Congo, Democratic Republic of
14
Eswatini/ Swaziland
14
Peru
13
Burkina Faso
12
Germany
12
Argentina
12
Pakistan
12
Haiti
11
East and Southern Africa
10
Tajikistan
9
Benin
9
Albania
9
Brazil
9
South Sudan
9
Armenia
8
Venezuela
8
Syria
7
West and Central Africa
7
Georgia
7
El Salvador
6
Cameroon
6
Paraguay
6
Vietnam
6
Thailand
5
Laos
5
Guinea
5
Middle East and North Africa
5
Bolivia
5
Moldova
5
Sudan
5
Afghanistan
4
Eastern Europe and Central Asia
4
Southern Africa
4
Madagascar
4
North Macedonia
3
Timor Leste/ East Timor
3
Iran
3
Estonia
3
USA
3
Jordan
3
Western Pacific Region
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Bhutan
3
Iraq
3
Somalia
3
Ecuador
3
Burundi
2
Morocco
2
Saudi Arabia
2
North America
2
Papua New Guinea
2
Yemen
2
Romania
2
Poland
2
Angola
2
North Korea
1
Switzerland
1
Mexico
1
Gambia
1
Chile
1
Singapore
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Ireland
1
Gabon
1
Turkmenistan
1
Belgium
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Nicaragua
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Central African Republic
1
Honduras
1
Mali
1
Libya
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1505
Clinical Guidelines
242
Public Health
99
Women & Child Health
84
Key Resources
64
Capacity Building
41
Pharmacy & Technologies
31
Annual Report MEDBOX
2
Toolboxes
TB
751
HIV
490
AMR
133
COVID-19
81
Mental Health
70
NTDs
70
Pharmacy
66
Caregiver
55
Refugee
41
Health Financing Toolbox
36
Ebola & Marburg
33
NCDs
33
Global Health Education
29
Conflict
27
Polio
23
Rapid Response
20
Disability
19
Natural Hazards
13
Planetary Health
10
Malaria
10
Social Ethics
6
Specific Hazards
4
Cholera
2
South Sudan
1
Zika
1
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
Tuberculosis cases, TB deaths
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
WHO/CDS/TB/99.272
Distr.: General, Original: French
The "Norma Técnica de Salud para la Atención integral de las Personas Afectadas por Tuberculosis" (Technical Health Standard for the Integral Care of Persons Affected by Tuberculosis)
incorporates important innovations that standardise the programmatic management of tuberculosis (TB).
Ce plan stratégique 2013- 2017 s’inscrit dans la continuité du précédent et a pour but de contribuer à la réduction de la charge de la tuberculose au Sénégal d’ici 2015 conformément aux Objectifs du Millénaire (OMD 6 Cible 8) et aux cibles du partenariat Halte à la tuberculose.
Les i...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
2nd edition. Children with TB comprise about 10-12% of the total TB cases diagnosed in the country. This burden is likely to be higher given the challenges in diagnosing TB in children. The symptoms of TB in children mimic those of other childhood diseases. Children do not readily expectorate and th...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective ...
Le présent manuel fournit les directives actualisées à l'intention des médecins, infirmiers et laborantins confrontés à la tuberculose multirésistante (TB-MR). Il remplace la version élaborée en 2007 et s’est enrichi de l’expérience pratique de six années. Il s’appuie sur les recomm...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
Se estima que unos 10 millones de personas contrajeron tuberculosis (TB) en el 2019 y que a unos 3 millones de ellas no se les diagnosticó ni se les notificó la enfermedad. Con el propósito de poner fin a la epidemia mundial de la tuberculosis para el 2030, sigue siendo necesario ampliar la capac...
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about MDR-TB must be improved, and follow-up of MDR-TB patients who are living with HIV and of those affiliated with the...
The goal of this assessment is to determine how far USAID/Senegal’s HIV/AIDS and TB programs have achieved their specific objectives with regard to identifying potential leads for improvement that are likely to make it easier to reach the planned results. After responding to the issues developed i...
